Clinical Trial Update: Using ctDNA to Determine Therapies for Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether circulating tumor DNA (ctDNA) can guide therapy choices for non-small cell lung cancer. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non Small Cell Lung Cancer, Complete Surgical Resection | Phase 2 | Status: RECRUITING